The index futures are predicting a slight increase in opening of U.S. markets. Shortly before the opening of Wall Street, futures on the Standard & Poors'500 yielded 0.02% at 1121.6 points and the Nasdaq 100 index futures advanced 0.08% to 1895.75 points. The Dow Jones is expected to open in tiny increase of 0.02% at 10,619 points.
Wall Street has ended sharply higher Monday, nearly 2% to a high of 10 weeks. The decline of the dollar in particular has boosted energy stocks and mining. The banking sector also supported the document, benefiting from strong results that are published by big European names including BNP Paribas and HSBC. Bank of America gained 2.85% to 14.44 dollars, JPMorgan Chase, 3.38% to 41.64 dollars.The dollar resumed a few colors on Tuesday but remains under pressure, while oil continues to benefit from macroeconomic indicators that reassured investors about the pace of recovery in the global economy.
On the menu of macroeconomic indicators on Tuesday, investors will have the choice between car sales for the month of July, expenditures and household incomes in July, which will be unveiled at 14.30, the industrial orders for June, expected to 16:00, along with the promise of home sales in June
As for listed companies, Pfizer presented on Tuesday, before the market, its second quarter results, as well as Dow Chemical, and Procter & Gamble, those of Q4. Electronic Arts will publish the results after the market's first quarter.
While RIM has today with her new Blackberry.RIM could still react to the decision reaffirmed the UAE who want no more of the famous phone. In local media, the UAE were in effect Tuesday defended against criticism of their decision to suspend U.S. from October 11 major services of multimedia BlackBerry phone.
Morgan Stanley will be closely watched. The U.S. bank would have in fact decided to split the fund FrontPoint risk investments, acquired in 2006 by U.S. TV network CNBC that the deal is completed by three months.This split would allow Morgan Stanley to comply with new requirements of the Dodd-Frank legislation on financial regulation, which limits the bank's own brokerage and speculative positions.
Sanofi-Aventis has sent the U.S. biotech group Genzyme (which gained 1.15% to 70.36 dollars on Monday night) a letter citing his interest in American society, said Monday a source close to the deal, adding that the two companies were discussing the offer.